✦ LIBER ✦

Good response to moderate plaque psoriasis with ustekinumab in a patient with demyelinating disease and metabolic syndrome

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transition to ustekinumab in patients wi

✍ Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolom 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

PSS4 Evidence-Based Budgetary Impact Ana

✍ Martin, S.; Carter, C. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Comparison of response rates and drug co

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy and safety of ustekinumab in Ja

✍ Atsuyuki IGARASHI; Takeshi KATO; Mai KATO; Michael SONG; Hidemi NAKAGAWA; THE JA 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB

Cost Utility Analysis Based on a Head-to

✍ Feng Pan; Nicole C. Brazier; Neil H. Shear; Farah Jivraj; Brad Schenkel; Ruth Br 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Baseline nail disease in patients with m

✍ Phoebe Rich; Christopher E.M. Griffiths; Kristian Reich; Frank O. Nestle; Richar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 304 KB